Generalized Anxiety Disorder
Severe, ongoing anxiety that interferes with daily activities.
Generalized anxiety disorder can occur at any age.
The condition has symptoms similar to panic disorder, obsessive-compulsive disorder, and other types of anxiety. These symptoms include constant worry, restlessness, and trouble with concentration.
Treatment may include counseling and medications, such as antidepressants.
US Patients: Generalized Anxiety Disorder
World Patients: 3-5%
Age Onset: M;W2
Brain Area: Age 31
Symptoms: more amygdala and medial pfc activities; hippocampus, insula & orbitofrontal cortex
Progression: excessive, uncotnrollable and often irrational worry about ev ents or activities. frequent autonomic arousal
Causes: 60% develop depression
Medications: may be hereditary (40%)or genetic + environment-actual experiences
Therapies: norepinephrine inhibitors, antianxiety drugs, (many, many drug options-but many with possibly fatal side effects)
CBT-less catastrophizing, and other CBT orientations, relaxation, mindfulness, physical exercise
Youtube Video: What is Generalized Anxiety Disorder?
Amazon or Library Book: Overcoming Generalized Anxiety Disorder
Support Group: nami.org; 800-950-6264 (National Alliance on Mental Illness)
Contact you local Social Security office for possible Disability Benefits through their Disability Determination Services,
4 CURRENT ARTICLES
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- An Evaluation of the Impact of Mental Illness on Postoperative Breast Reconstruction Revision Surgeryby Jessica F Saifee on January 26, 2023
CONCLUSION: Patients who underwent autologous reconstruction for breast cancer demonstrated no difference in rates of secondary surgical revision, regardless of a concurrent mental health history.
- Internet-delivered treatment for patients suffering from severe functional somatic disorders: Protocol for a randomized controlled trialby Heidi Frølund Pedersen on January 26, 2023
CONCLUSIONS: This study is the first study to test an internet-delivered treatment program for FSD, multi-system type and has the potential to show the importance of making evidence-based internet-delivered treatment for FSD more accessible.
- Prevalence and effects of sleep-disordered breathing on middle-aged patients with sedative-free generalized anxiety disorder: A prospective case-control studyby Tien-Yu Chen on January 26, 2023
CONCLUSION: Average age 55 years and mean BMI 23 kg/m² patients with GAD and matched controls had an undiagnosed SDB prevalence of approximately 50%. SDB correlated with worsening anxiety severity and reduced cardiac autonomic function. Moreover, age and BMI were considered major risk factors for predicting undiagnosed SDB.
- Functional tic-like behaviours during the COVID-19 pandemic: Follow-up over 12 monthsby Adriana Prato on January 26, 2023
CONCLUSION: Our data suggest that several characteristics in clinical course and their phenomenology can help clinicians to distinguish functional tic-like behaviours from organic tics. Our results also suggest a better outcome for tics and anxiety symptoms respect on other comorbidities. A prompt diagnosis and management not only of tics but also comorbidities are recommended, as generally conventional pharmacotherapy for tics does not have positive effects on these patients.